N-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide

C51H57F4N15O8S2 — CID 157079631

IUPACN-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCCCN(C)S(=O)(=O)c1ccc(OC(F)F)c(-c2nn(C[C@H]3CCCN3C)cc2NC(=O)c2cnn3cccnc23)c1.CN1CCC[C@@H]1Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(S(C)(=O)=O)ccc2OC(F)F)n1
InChIInChI=1S/C27H32F2N8O4S.C24H25F2N7O4S/c1-4-11-35(3)42(39,40)19-8-9-23(41-27(28)29)20(14-19)24-22(17-36(33-24)16-18-7-5-12-34(18)2)32-26(38)21-15-31-37-13-6-10-30-25(21)37;1-31-9-3-5-15(31)13-32-14-19(29-23(34)18-12-28-33-10-4-8-27-22(18)33)21(30-32)17-11-16(38(2,35)36)6-7-20(17)37-24(25)26/h6,8-10,13-15,17-18,27H,4-5,7,11-12,16H2,1-3H3,(H,32,38);4,6-8,10-12,14-15,24H,3,5,9,13H2,1-2H3,(H,29,34)/t18-;15-/m11/s1
InChIKeyADJODLDMZOXZPL-GNPGSHRGSA-N
MW1148.24 g/mol
LogP6.52
Rot. Bonds19

About N-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide

N-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide (PubChem CID 157079631) has the molecular formula C51H57F4N15O8S2 and a molecular weight of 1148.24 g/mol. Its IUPAC name is N-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.

Molecular Properties

Compound NameN-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
PubChem CID157079631
Molecular FormulaC51H57F4N15O8S2
Molecular Weight1148.24 g/mol
Exact Mass1147.39
IUPAC NameN-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide
SMILESCCCN(C)S(=O)(=O)c1ccc(OC(F)F)c(-c2nn(C[C@H]3CCCN3C)cc2NC(=O)c2cnn3cccnc23)c1.CN1CCC[C@@H]1Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(S(C)(=O)=O)ccc2OC(F)F)n1
InChIInChI=1S/C27H32F2N8O4S.C24H25F2N7O4S/c1-4-11-35(3)42(39,40)19-8-9-23(41-27(28)29)20(14-19)24-22(17-36(33-24)16-18-7-5-12-34(18)2)32-26(38)21-15-31-37-13-6-10-30-25(21)37;1-31-9-3-5-15(31)13-32-14-19(29-23(34)18-12-28-33-10-4-8-27-22(18)33)21(30-32)17-11-16(38(2,35)36)6-7-20(17)37-24(25)26/h6,8-10,13-15,17-18,27H,4-5,7,11-12,16H2,1-3H3,(H,32,38);4,6-8,10-12,14-15,24H,3,5,9,13H2,1-2H3,(H,29,34)/t18-;15-/m11/s1
InChIKeyADJODLDMZOXZPL-GNPGSHRGSA-N
XLogP6.52
TPSA250.68 Ų
H-Bond Donors2
H-Bond Acceptors20
Rotatable Bonds19
Heavy Atoms80
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001148.24
LogP ≤ 56.52
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1020

Analyze N-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The IUPAC name of N-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide (CID 157079631) is N-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide.
What is the SMILES notation for N-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The canonical SMILES for N-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide is CCCN(C)S(=O)(=O)c1ccc(OC(F)F)c(-c2nn(C[C@H]3CCCN3C)cc2NC(=O)c2cnn3cccnc23)c1.CN1CCC[C@@H]1Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(S(C)(=O)=O)ccc2OC(F)F)n1.
What is the InChIKey of N-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
The InChIKey is ADJODLDMZOXZPL-GNPGSHRGSA-N. The full InChI is InChI=1S/C27H32F2N8O4S.C24H25F2N7O4S/c1-4-11-35(3)42(39,40)19-8-9-23(41-27(28)29)20(14-19)24-22(17-36(33-24)16-18-7-5-12-34(18)2)32-26(38)21-15-31-37-13-6-10-30-25(21)37;1-31-9-3-5-15(31)13-32-14-19(29-23(34)18-12-28-33-10-4-8-27-22(18)33)21(30-32)17-11-16(38(2,35)36)6-7-20(17)37-24(25)26/h6,8-10,13-15,17-18,27H,4-5,7,11-12,16H2,1-3H3,(H,32,38);4,6-8,10-12,14-15,24H,3,5,9,13H2,1-2H3,(H,29,34)/t18-;15-/m11/s1.
What are the key properties of N-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide?
N-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide has a molecular weight of 1148.24 g/mol, XLogP of 6.52, 19 rotatable bonds, 2 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[2-(difluoromethoxy)-5-[methyl(propyl)sulfamoyl]phenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[3-[2-(difluoromethoxy)-5-methylsulfonylphenyl]-1-[[(2R)-1-methylpyrrolidin-2-yl]methyl]pyrazol-4-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide is sourced from PubChem (CID 157079631), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).